Phase 2 Trial of Dasatinib with Philadelphia Chromosome+ ALL - Results were similar to studies with imatnib - 101931

Spotlight
Video

Phase 2 Trial of Dasatinib with Philadelphia Chromosome+ ALL - Results were similar to studies with imatnib

ASHReport has 256 videos Subscribe Here

Loading........
Description: Stephen Hunger, MD from Children's Hospital of Philadelphia discusses phase 2 trial of Dasatinib with Philadelphia Chromosome+ ALL and how the results were similar to studies with imatnib at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/23/18
Added : 3 months ago